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FUSION PORE CONDUCTANCE TO DETERMINE THE EFFECTS OF 
MUTATING THE STRUCTURE OF INFLUENZA VIRUS HEMAGGLUTININ
REBECCA D. WACHTER
ABSTRACT
Enveloped viruses, such as influenza, infect cells by fusing their viral 
envelope with the cell membrane. The fusion pore is a macromolecular structure that 
links two membranes that are fusing. This paper will focus on the fusion pore initiated
by the hemagglutinin (HA) protein of influenza virus upon infection of a host cell. 
Mutations in the HA protein can alter the time-course and structure of the developing 
fusion pore. While there is a clear relationship between HA’s structure and the dynamic 
opening of the pore, the initial 3D structure of the fusion pore as it first begins to form 
remains unknown. We have attempted to address this unanswered question by measuring 
fusion pore conductance – a one dimensional electrophysiological measurement – at 
millisecond time resolution for both wild type and mutant HA proteins, using an 
automated patch clamp apparatus. Correlating the entire life history of the fusion pore 
with the snapshots we get from 3D imaging (cryo-electron tomography) would allow us 
to capture the initial pore opening, as well as better understand the effect that mutating 
the structure of HA has on influenza viral infection. At this time, we have not yet been 
able to observe the fusion event; however, we do believe that future experimentation 
using fusion pore conductance to investigate the effects of HA’s structure on influenza 
viral infection are both promising and necessary.
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INTRODUCTION
Fusion Pore
I. General Overview
In a virus, nucleic acids are contained within a protective protein shell called a 
viral capsid. It is through the transfer of this genetic material that viruses are able to 
infect host cells. Some viruses are further classified as enveloped viruses, in which case 
the capsid itself is enclosed in a lipid bilayer. One of the ways these enveloped viruses 
can enter a host cell is through receptor-mediated endocytosis. At this stage, however, the 
virus is enclosed in an endosome, isolated from the host cell’s cytosolic compartment. In 
order for it to infect the host cell, a necessary fusion event must take place between the 
viral envelope and the cell’s endosomal membrane (Judith White, Kielian, & Helenius, 
1983).
This necessary fusion event proceeds through the formation of a fusion pore, or 
“exocytotic pore,” as it was first described (Zimmerberg, Curran, Cohen, & Brodwick, 
1987). The formation of the fusion pore – a macromolecular structure that connects two 
fusing membranes – is the first detectable event leading to the main fusion event 
associated with infection (Zimmerberg, Blumenthal, Sarkar, Curran, & Morris, 1994).
Therefore, studying its 3D structure would enhance our understanding of how enveloped 
viruses, such as influenza, gain access to the host cell’s intracellular compartment during 
infection. It is important to note that infection does not occur during this membrane-
membrane fusion event until the pore itself begins to open. Therefore, a great deal of 
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work is currently being done to elucidate the 3D structure and dynamic function of the 
fusion pore during its first few milliseconds of opening, marking the onset of influenza 
viral infection.
The formation of a fusion pore is not, however, limited to cases of viral infection 
of host cells. It is a phenomenon that has been observed in various biological processes, 
primarily those involving exocytosis, (Zimmerberg et al., 1987; Breckenridge & Almers, 
1987b; M. Lindau, Nüsse, Bennett, & Cromwell, 1993). At the neuronal synapse, 
neurotransmitters waiting to be released from the presynaptic neuron are housed in small 
membrane-bound vesicles, or granules.  In order for the neurotransmitters to be released 
from the presynaptic cell, the granular membrane must fuse with the presynaptic neuronal 
membrane. This exocytotic fusion event is contingent upon the formation of a fusion pore
(Monck & Fernandez, 1994). Since the fusion pore physically could limit how much 
neurotransmitter is able to pass through from the presynaptic neuron into the synapse at a 
given point in time, it has been postulated that the diameter and timing of the pore 
opening has a significant regulatory role in neuronal signaling (Fesce, Grohovaz, 
Valtorta, & Meldolesi, 1994; Staal, Mosharov, & Sulzer, 2004; He, Wu, Mohan, & Wu, 
2006).
The fusion pore is also known to play a key role in the immunological response 
and has been studied extensively in mast cell degranulation. In order for mast cells to 
release histamine and heparin, the granules in which these compounds are contained must 
fuse with the plasma membrane. This exocytotic event proceeds through the formation of 
a fusion pore and, therefore, many of the early fusion pore discoveries were made by 
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studying the exocytotic events in mast cells. A variety of different techniques have 
proven extremely useful in studying the fusion pore in various models. Each of these 
techniques, however, has its own limitations, which will be discussed next. 
II. Techniques for studying the fusion pore
i. Freeze fracture and electron microscopy
In 1980, Chandler and Heuser were able to capture the first images of the 
exocytotic fusion event in degranulating mast cells using quick-freezing and freeze 
fracture techniques (Chandler & Heuser, 1980). By stimulating degranulation in rat 
peritoneal mast cells and subsequently quick-freezing the membrane, they were able to 
arrest and observe exocytotic fusion events under the electron microscope. An electron 
microscope has higher magnification and resolving power capabilities than that of a light 
microscope. This allows for significantly higher-quality snapshots of small objects, 
rendering it an invaluable tool used for imaging at the cellular level. Using the electron 
microscope, Chandler and Heuser reported the observation of pores in the early stages of 
rapid exocytosis with diameters as small as 0.05 μm. However, the fusion pore created by 
influenza virus is much smaller than the fusion pore created by a degranulating mast cell. 
Furthermore, the initial opening of the fusion pore occurs in a very rapid, step-wise 
manner, making it extremely unlikely for the electron microscope to capture a snapshot 
of the fusion pore during its initial opening (Fernandez, Neher, & Gomperts, 1984).
While the electron microscope is certainly a valuable tool in studying the 3D structure of 
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the influenza-induced fusion pore, it alone does not enable us to fully understand the 
pore’s structure upon its initial, dynamic opening.
ii. Electrophysiology in Mast Cells
Mast cells of a mutant “beige” mouse have also served as a particularly useful 
model in studying the fusion pore because they have “giant” granules (approximately 4 
μm in diameter) whose exocytotic events are easier to study than those of smaller, 
average-sized mast cell granules (0.5 – 1.0 μm in diameter) (Chi & Lagunoff, 1975). By 
simultaneously obtaining electrophysiological measurements and light microscopy 
videos, scientists were able to observe singular fusion events (exocytosis of one granule 
at a time) in these mast cells (Zimmerberg et al., 1987; Breckenridge & Almers, 1987a).
The electrophysiology measurements were used to mark the first detectable sign of the 
fusion event (an event too small and rapid to be identified by video alone). This is very 
useful to our study as we, too, will combine electrophysiology recordings with advanced 
imaging techniques to correlate the dynamic opening and 3D structure of the pore 
resulting from a single fusion event. Because the initial opening of the fusion pore is so 
small and quick to form, light microscopy videos are not capable of capturing the initial 
event. Electrophysiology, however, has ways of detecting this fusion event, which will be 
discussed in detail shortly. Therefore, the electrophysiology recordings serve as marker, 
indicating when exactly the first detectable fusion event occurred. 
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Though this paper will focus solely on the fusion pore that is formed during 
infection by the influenza virus, it is apparent that having a way to measure and 
investigate the entire life history of the fusion pore is of great importance to many. While 
a great deal has been learned from the techniques and findings mentioned above, there 
still remains a big unanswered question in the field concerning the dynamic opening of 
the initial fusion pore. There is a protein on the influenza virus, called hemagglutinin 
(HA), that is responsible for initiating the formation of the fusion pore. Engineered-
mutants of the HA protein have been discovered to form pores that are smaller and 
slower to develop as determined by fluorescence microscopy (L. V. Chernomordik, 
Frolov, Leikina, Bronk, & Zimmerberg, 1998).  Some mutants, such as GPI-HA
(glycosylphosphatidylinositol-HA) initiate the formation of a fusion intermediate, but fail 
to elicit pore opening altogether (G. W. Kemble, Danieli, & White, 1994). Such studies 
have shown that there is a direct relationship between HA’s structure and the dynamic 
opening of the pore; however, fluorescence microscopy as well as many of the other 
techniques previously discussed, have failed to capture the 3D structure of the HA-
mediated fusion pore during its initial opening. We plan to address this unanswered 
question by measuring fusion pore conductance – a one dimensional electrophysiological 
measurement – at millisecond time-resolution for both wild type and mutant HA proteins. 
By correlating the entire life history of the fusion pore with the snapshots we get from a 
3D imaging technique (cryo-electron tomography), we hope to not only capture the initial 
pore opening, but also determine the effect of mutating the structure of the HA protein on 
influenza viral infection. 
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III. Stages of the Fusion Pore
From the data that has been collected using the techniques mentioned above, it 
has been learned that the development of the fusion pore occurs over a series of stages.  
These stages, depicted in Figure 1, will be discussed in sequential order. First, the two 
membranes that will ultimately connect via the fusion pore are brought together (Niles & 
Cohen, 1987).  In the case of influenza virus, these two membranes are the viral envelope 
and the host cell’s endosomal membrane. There is a specific protein on the outer face of 
the influenza virus that anchors onto the endosomal membrane (J. M. White & Wilson, 
1987). This protein, hemagglutinin, inserts itself into the cellular endosomal membrane 
and holds the viral and cellular membranes in close proximity to one another so they can 
begin to fuse (figure 1A).
The next stage in the formation of the fusion pore is called hemifusion (figure 
1B). As its name implies, the two membranes being held together by the HA protein 
begin to fuse, but only partially (Kemble, Danieli, & White, 1994). While the two 
contacting monolayers (the outer viral monolayer and inner endosomal layer) fuse 
together, the two distal monolayers remain distinctly separated (Chernomordik & Kozlov, 
2005). The lipid mixing that occurs between the two contacting membranes forms a stalk-
like structure (Kozlovsky & Kozlov, 2002).  Though this stalk serves as a physical 
connection between the viral and endosomal membranes, the pore has not yet formed.  
Therefore, the virus is still isolated from the host’s intracellular compartment at this stage 
of the process.
7Figure 1: Stages of influenza virus-induced fusion pore. (A) Hemagglutinin on the 
influenza viral envelope initiates the formation of the fusion pore by anchoring onto the 
endosomal membrane, bringing the two bilayers in close proximity. This occurs in a low 
pH environment which is crucial for activating the fusion peptide on the HA2 subunit. 
(B) Hemifusion occurs when the two contacting monolayers undergo lipid mixing and 
form a stalk-like structure. The distal monolayers remain separated at this stage and 
therefore pore opening is not yet observed. (C) The two distal monolayers fuse with one 
another creating a pore through the center of the membranes. This fusion pore connects 
the intracellular compartments of the virus and host cell, enabling influenza viral 
infection through the transfer of genetic material. 
= 
= 
=
Viral 
envelop
Endosomal 
membrane
HA + fusion 
peptide
HA Binding Hemifusion Fusion 
(A) (B) (C)
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Following hemifusion is the initial opening of the pore (Spruce, Iwata, & Almers, 
1991). This stage occurs when the two distal monolayers (inner viral envelope and outer 
endosomal) fuse in a way that creates a small pore in the center of the structure (Lu, 
Zhang, McNew, & Shin, 2005; Reese, Heise, & Mayer, 2005).  Before the fusion pore 
begins to open, the influenza virus’ envelope and the host cell’s endosomal membrane are 
two distinctly separate bilayers, which serve as barrier between the cytosolic 
compartments of the influenza virus and host cell.  Once the distal monolayers fuse 
together, the virus and host cell share one continuous membrane, conjoined by the fusion 
pore (Melikyan, Brener, Ok, & Cohen, 1997). The fusion pore grows and dilates rapidly, 
giving the virus an entry way into the host cell’s cytosol (Blumenthal, Sarkar, Durell, 
Howard, & Morris, 1996). It is at this stage, the virus is able to transfer its genetic 
material into the host cell, marking the onset of infection.
Hemagglutinin Fusion Protein 
I. General Overview
Hemagglutinin (HA) is one of the two major glycoproteins located on the outer 
surface of the influenza virus. The other major glycoprotein that has been observed, 
though not as abundant as HA, is neuraminidase (NA).  Each strain of influenza virus is 
classified based on their combination of HA and NA surface proteins (Stevens & Donis, 
2007). For instance, the H1N1 strain and the H5N1strain have different hemagglutinin 
glycoproteins (H1 and H5, respectively) on their outer surface, but express the same 
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neuraminidase (N1). Hemagglutinin is of particular interest because, of these two 
proteins, it is the one that allows the influenza virus to bind to and fuse with a host cell.
Hemagglutinin readily binds to target cells whose membranes contain sialic acid-
coated receptors (Weis et al., 1988). In the human body, the host cells whose sialic acid 
sugars get bound by influenza virus are typically epithelial cells of the nose, throat, and 
lungs (Lg & Jc, 1989). Upon HA binding to the sialic acid-coated receptors, the entire 
virus particle is taken up by the host cell via receptor-mediated endocytosis. This process 
creates an endosome, which encompasses the virus particle and isolates it from the host 
cell’s cytosol. In order to release its content into the host cell, a second event – also 
mediated by hemagglutinin – must occur (White, Kielian, & Helenius, 1983). The viral 
envelope must fuse with the endosomal membrane to form a fusion pore through which 
the virus gains access to the host’s cytosolic compartment. Hemagglutinin facilitates this 
process by anchoring onto the endosome and initiating the formation of a fusion pore, as 
discussed in the previous section (Niles & Cohen, 1987). Through a series of dynamic 
events, the fusion pore elongates and opens until the viral and endosomal membranes 
fuse (Blumenthal et al., 1996). At this stage, the virus is able to infect the host cell 
through a transfer of its genetic material.  
II. HA Structure and Conformation
Since hemagglutinin mediates various events throughout the infection process / 
formation of the fusion pore, it is important to look at how its structure lends to its 
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functional versatility. Like many other fusion proteins, HA is classified as a Class I 
integral membrane protein (Durell, Martin, Ruysschaert, Shai, & Blumenthal, 1997). As 
was first seen in electron micrographs, the HA glycoprotein projects outward from the 
Figure 2: Conformational changes in hemagglutinin of influenza virus. Different 
conformations of hemagglutinin throughout the influenza virus life cycle. Molecular 
structures obtained using X-ray crystallography. (A) Precursor hemagglutinin prior to 
being cleaved and (B) after being cleaved into functional HA1 and HA2 subunits.  Note: 
Asterisk* denotes cleavage site. (C) HA2 subunit only, after being activated by a low-pH. 
The fusion peptide is exposed and able to initiate membrane-membrane fusion (figure 
taken from Stevens & Donis, 2007). 
 11 
external surface of the influenza virus, and has spike-like appearance (Compans, Klenk, 
Caliguiri, & Choppin, 1970). Hemagglutinin is a homotrimeric protein, approximately 
220 kDa and 135 Å in length. Each of its three monomers is synthesized and inserted into 
the lumen of the ER as a precursor (H0) (figure 2B).  As it is translocated to the 
membrane via secretory vesicles, the H0 become glycosylated and cleaved into two 
different subunits: HA1 and HA2 (Luo, 2012). Therefore, a fully functional HA protein is 
comprised of three monomers, each of which have been glycosylated and cleaved into 
two subunits (HA1 and HA2). HA has a smaller C-terminal domain, which spans the viral 
envelope, as well as a larger N-terminal domain protruding outward from the virus 
(Stevens & Donis, 2007). The N-terminus of the HA2 subunit is hydrophobic, and is 
referred to as the “fusion peptide.”  This is the portion of the HA protein responsible for 
anchoring onto the endosomal membrane and initiating the formation of the fusion pore. 
In order for HA’s fusion peptide to initiate the formation of the fusion pore, the 
protein must be activated via a conformational change.  This change is triggered by a low 
pH environment inside the endosome (Moore et al. 1993; Broder and Dimitrov 1996). At 
a neutral pH, the HA protein is in its closed form.  However, inside the lumen of the 
endosome, the virus particle is exposed to a low pH of approximately 5, causing a 
conformational change in the HA protein (Bullough, Hughson, Skehel, & Wiley, 1994).
As a result, the fusion peptide – a hydrophobic region that is located on the N terminus of 
the HA2 subunit, initially buried inside the glycoprotein homotrimer – becomes exposed 
(figure 2C). In this open conformation, the fusion peptide extends towards, and inserts 
itself into the endosomal membrane (Blumenthal et al., 1995). Anchored to one another 
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by the HA fusion peptide, the two membranes (virus and endosomal) undergo lipid 
mixing. The fusion pore begins to form, ultimately leading to the main fusion event.
Electrophysiology of Our Experiment
Electrophysiology recordings have served as an invaluable technique in studying 
the dynamics of the fusion pore. Of particular interest to us is the ability for 
electrophysiological experiments to mark the initial stages of the fusion pore opening that 
cannot be captured using other techniques.  Our goal is to measure the changes in 
conductance throughout the formation of the hemagglutinin-induced fusion pore at 
millisecond time resolution for both wild type and mutant HA-expressing cells.  
The whole cell patch clamp technique was developed in 1977 by Neher and 
Sackman, which, for the first time, made it possible to record current through single-ion 
channels ( Neher & Sakmann, 1976). This technique has many different applications for 
studying the electrical activity across a cell membrane, though the two that we are most 
interested in for our study are conductance and capacitance.  Conductance measures the 
ease at which ions flow through a channel (Breckenridge & Almers, 1987a). The greater
the opening, the easier it is for ions to flow (higher conductance), resulting in an increase 
in current. In other words, we would expect the conductance through the dilating pore to 
correspondingly increase. Although the mathematics for calculating the fusion pore rely 
on both capacitance and conductance measurements of cells, they are all based on a very 
simple, yet essential equation known as Ohm’s law:
V = I R
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where V = potential difference, I = current, and R = resistance. This equation tells us that 
current (I) flows through a conductor in proportion to the potential difference (V) across 
that conductor (Ohm, 1827), (Ohm, 1891).  The ratio of these two values (V/I) yields a 
constant known as resistance. Knowing the value of resistance allows us to easily 
calculate the conductance through a membrane, as conductance is the reciprocal of 
resistance. Therefore, Ohm’s law can be rewritten as: 
I = G V
where G = conductance.  In the whole cell configuration, we are able to apply a command 
voltage to a patched cell, record the resulting current through the cell membrane, and 
subsequently solve for resistance. Then, we can calculate conductance of the whole cell 
using the equation above. When the fusion pore opens, the resistance to charging the 
capacitor of the second cell is dramatically lower, and the capacitance of the overall 
circuit of both cells increases (Zimmerberg et al., 1987). It is through this increase in 
capacitance that the fusion pore conductance can be measured.
It is important to note that, although in humans, the influenza virus binds to sialic 
acid-coated receptors on the exterior of epithelial cells lining the respiratory tract, our 
experiments use a different model to investigate this fusion event. Specifically, we obtain 
our whole cell patch clamp recordings from pre-bound HA-expressing fibroblasts and 
human red blood cells. While these cell pairs are pre-bound (also via sialic-acid coated 
receptors), they are not yet fused.  Therefore, we initially record from a single entity in 
the bound state (either red cell or fibroblast) whose intracellular compartment is 
completely isolated from the other, as shown in figure 3A. Once the two membranes fuse 
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and the fusion pore begins to open, the recordings we obtain reflect the electrical activity 
across the newly joined, continuous unit (figure 3B). 
Figure 3: Whole cell configuration before and after fusion. Note: illustrations are not 
drawn to scale. (A) Prior to fusion pore opening, whole cell recordings reflect the 
electrical activity across the membrane of the patched cell, only (orange). (B) As soon as 
the cells fuse, the recordings reflect electrical activity across both membranes, now 
continuous with one another. This increase in membrane surface area as a result of the 
two membranes fusing is marked by a proportional increase in capacitance at the moment 
of fusion.
In order to mark the initial opening of the fusion pore between the red blood cell 
and HA-expressing fibroblast, we will focus on a second electrophysiological 
measurement: capacitance. Using capacitance measurements as an indicator of a 
membrane-membrane fusion event is a well-established electrophysiological application
(E Neher & Marty, 1982). Membrane capacitance measures an object’s ability to store an 
electrical charge. Cell membranes, in general, have a specific capacitance of 1 μF / cm2
(A) Pre-fusion (B) Post fusion
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(Cole, 1968). Since this ability to store charge is measured per unit of area, we can see 
that capacitance varies in proportion to surface area of the membrane, such that a larger 
cell (with a greater surface area) has a higher capacitance than a smaller cell. This 
relationship is extremely relevant to our experiments because during fusion, two 
membranes add together and become one continuous bilayer.  Therefore, a fusion event –
during which the total surface area of the cell membrane is increased – should be marked 
by a proportional increase in capacitance (Plonsky & Zimmerberg, 1996).
Since our goal is to observe the fusion event over the course of time, we need to 
obtain real-time continuous recordings from our patched cell. In order to record 
capacitance continuously, a voltage needs to be applied to the membrane in the form of a 
sine wave, while the resulting sinusoidal current is measured. If the frequency of the sine 
wave is high enough, the resulting current is expected to be proportional to capacitance 
(E Neher & Marty, 1982). However, introducing a high frequency sine wave also 
increases unwanted noise into our system. In order to optimize both time resolution and 
noise level, we use a phase sensitive detector called a lockin amplifier (HEKA EPC 10 
USB amplifier) to analyze the resulting current and report the membrane capacitance of
our patched cell.
Electrophysiology experiments are extremely sensitive to various confounding 
factors, which can make it difficult to observe the small and rapid changes in capacitance 
and conductance over the course of fusion pore opening. A key component of our 
experimental setup is ensuring that we are able to obtain recordings at an appropriate time 
resolution to capture the rapid dynamics of the initial pore.  We also must ensure that our 
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system is isolated enough from outside electrical sources that have the potential to 
interfere with our data by introducing levels of noise that would mask the detection of 
such small fluctuations. We are confident that the low-noise automated patch clamp 
apparatus (Nanion Technologies) will allow us to obtain conductance measurements at 
millisecond time resolution, as well as capacitance measurements with a noise level that 
is less than 10 fF. These experimental conditions should allow us to obtain the 
electrophysiological information we need to elucidate the initial fusion pore opening 
between human red cells and HA-expressing fibroblasts. 
MATERIALS AND METHODS
Automated Electrophysiology Rig
Our electrophysiology experiments were conducted using the Port-a-Patch 
automated, low-noise patch clamp apparatus from Nanion Technologies GmbH, 
illustrated in figure 4. The execution of our electrophysiology experiments differs from 
that of traditional whole cell patch clamp experiments on various levels. The success of a 
traditional patch clamp experiment largely relies on the skill and dexterity of the 
experimenter. The Port-a-Patch, on the other hand, is entirely automated.  In order to 
understand our experimental methods and the materials we used, one must first 
understand the design of the Port-a-Patch, and how it differs from that of a traditional 
electrophysiology rig. 
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In a traditional rig, a very small and delicate, glass micropipette is used to patch 
onto a cell (Hamill, Marty, Neher, Sakmann, & Sigworth, 1981). The experimenter must 
prepare these micropipettes with great precision in order to ensure that a proper seal is 
able to form between the glass tip and the cell membrane. This requires an electrode 
puller – a heating device that melts, pulls, and separates a thin glass tube at its midpoint, 
creating two microelectrodes each with a cone- shaped tip.  This newly formed tip will 
ultimately form a seal with the target cell, and therefore, the tip of a microelectrode used 
for patching onto a smaller-sized cell would have a relatively smaller diameter than one 
used to patch onto a larger cell. The very tip of the micropipette is often fire-polished to 
create a smooth, blunted end so that when it comes in contact with the cell, it does not 
puncture it, but rather forms a tight, GOhm seal with a high resistance. In addition to 
preparing the micropipette, the experimenter is responsible for manually guiding it 
towards the cell and facilitating the formation of the seal. In electrophysiology 
experiments, being able to form a sufficiently tight seal between the micropipette and cell 
is considered a success in itself, as it is a very technical and challenging procedure to 
physically execute.  As a result of the difficult technique itself, the time it takes to set up 
and complete an experiment can be excessive, while the number of actual recordings 
obtained is often reduced.  
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Figure 4: Port-a-Patch automated electrophysiology apparatus. Note: illustrations are 
not drawn to scale. A. (a) The recording chip gets screwed directly onto the headstage. 
Upon suction, a cell gets lodged in an aperture (micron-sized diameter) in the center of 
the chip. (b) The external electrode contacts the external bath solution on top of the chip, 
and is grounded through (c).  (d) The internal electrode contacts the internal solution on 
the inner face of the chip. (e) Tubing connects the apparatus to a suction unit. B. On top 
of the recording chip, a cell from suspension gets lodged into the aperture when suction is 
applied, forming a GOhm seal between the membrane and borosilicate glass of the chip. 
The external electrode is shown immersed in the external bath solution. C. A cross-
section of a recording chip when whole cell configuration has been achieved. The 
external electrode records from the external buffer solution (extracellular environment) 
while the internal electrode contacts the internal buffer solution, now continuous with the 
cell’s intracellular fluid. Cross talk between these two electrodes gives us information 
regarding the electrical activity across the cell membrane.
A. B.
C.
(a)
(b) (d)
(c)
(e)
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The Port-a-Patch addresses the suboptimal success rate of traditional patch clamp 
experiments by automating nearly all of the steps required to achieve a GOhm seal. NPC-
1 recording chips are used in place of glass micropipettes.  These recording chips have a 
planar, borosilicate glass surface with a very small aperture (only microns in diameter) in 
the center. We add cells to the top of the recording chip while applying a gentle suction 
through the inner face of the chip.  This suction causes a cell to get lodged in the aperture, 
where a GOhm seal is formed between the borosilicate glass opening and the cell 
membrane. Therefore, this aperture is analogous to the opening of the glass micropipette 
used in traditional patch clamping. Just as the optimal size tip required for proper seal 
formation varies depending on the size of the target cell, we use recording chips with 
varying-sized apertures depending on the type of cell we hope to patch. For our 
experiments, we use the 5-10 Mega-Ohm (MOhm) NPC-1 chips (recommended by 
Nanion Technologies for patching erythrocytes).  The 5-10 MOhm designation simply 
refers to the initial 5-10 MOhm resistance across the chip’s aperture when the electrodes 
are in internal and external solutions added to the inner and outer face of the chip, 
respectively, prior to adding a cell suspension.  These standard solutions will be 
discussed shortly.  
The amount of time it would take for us to prepare a glass micropipette is 
condensed into the few seconds that it takes us to screw a new chip onto the top of our 
apparatus when we use the Port-a-Patch. If we are unable to patch onto a cell during an 
experiment, we simply remove the chip, screw on a new one, and are ready to start the 
next experiment. While these chips are disposable, a feature which allows for 
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experiments to be completed one after another in a particularly timely fashion, we found 
that they were in fact, able to be cleaned and reused. After each use, we saved our chips 
in a sealed container filled with deionized water and Alconox detergent, and let them 
soak overnight. We hypothesized that the detergent would remove any membrane or 
remaining cells, not only from the chip’s surface, but also from the aperture (had a cell 
been previously sealed). We found that the initial resistance across the chips reverted 
back to the 5-10 MOhm range, suggesting the aperture was clear of any remaining 
cellular components or unwanted residue. Moreover, soaking the chips in detergent did 
not prevent new cells from forming a GOhm seal, or subsequently achieving whole cell 
configuration. This technique did not slow down our experimentation (as we washed our 
chips in bulk at the start of the day, rather than in between each experiment) and was 
significantly cost effective. 
Furthermore, the great amount of skill that is required to patch onto a cell the 
traditional way is obsolete when using the Port-a-Patch.  As discussed, in traditional 
patch clamping, the experimenter must strategically guide the micropipette towards a 
target cell and facilitate the formation of a seal. When using the NPC-1 chips, a suction 
unit attached to the low-noise apparatus applies a brief negative pressure from the inner 
face of the chip and draws a cell from suspension into the aperture. The suction control 
unit is computer controlled by PatchControl software (Suction Unit and PatchControl 
from Nanion Technologies GmbH). At the push of a button, the PatchControl software 
runs through a pre-set protocol, commanding the suction control to apply varying 
amounts of positive and negative pressures until a cell is lodged into the recording chip 
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and a giga-ohm seal is achieved. While this is a less specific approach in the sense that 
we are unable to explicitly choose which cell we would like to record from, it certainly 
reduces the amount of time and effort it takes to perform a single experiment, in 
comparison to that of a traditional patch clamp rig.
Buffer Solutions
We use three different buffer solutions during our electrophysiology experiments: 
an internal solution, an external bath solution (referred to as “seal” solution), and a low-
pH fusion buffer.  Compositions for the internal and seal solutions are standard buffer 
solutions recommended by Nanion Technologies. The internal solution contains: 50 mM 
KCl, 10 mM NaCl, 60 mM KF, 20 mM EGTA, and 10 mM HEPES/KOH. This solution 
has a pH of 7.2 and an osmolarity of 285 mOsm. 5 μL of this internal solution is added to 
the inner face of the recording chip.
The external bath (seal) solution is comprised of 80 mM NaCl, 3 mM Kcl, 10 mM 
MgCl2, 35 mM CaCl2, 10 mM HEPES/HCl. It has pH: 7.4 and an osmolarity of 298 
mOsm. We refer to this buffer as “seal” solution because it increases the likelihood of 
achieving a GOhm seal as the relatively high concentration of divalent cations (Mg2+ and 
Ca2+) helps the cells stick to the borosilicate glass of the recording chip. Therefore, 5 μL
of this buffer is added to the outer face of the recording chip (where the cell suspension 
will subsequently be added). 
The final buffer solution that we use in our experiments is the low pH fusion 
buffer. Since hemagglutinin needs to be in a low pH environment in order to become 
 22 
activated, this buffer must be added in order to initiate the fusion event.  Without it, the 
HA-expressing fibroblasts will bind to the red blood cells, however they will not undergo 
fusion. This low pH buffer is made of 80 mM NaCl, 3 mM Kcl, 10 mM MgCl2, 35 mM 
CaCl2, 10 mM HEPES/HCl. It has a pH of 4.9, which mimics the low pH of the 
physiological endosome, where HA becomes activated. The osmolarity of this solution is
298 mOsm.  
The internal and external seal solutions are what allow us to measure the initial 
resistance through the aperture of the recording chip.  An internal Ag/AgCl2 electrode 
comes in contact with the internal buffer solution added to the inner face of the NPC-1
recording chip, while an external Ag/AgCl2 electrode makes contact with the external 
seal solution added to the top of the chip.  These electrodes are connected to an amplifier 
(HEKA EPC 10 Lockin Amplifier) and when a small voltage is applied, there exists a 
resulting current as ions move from one electrode to the other, through the chip’s 
aperture. The amount of ions that can flow through is dependent on the size of the 
aperture, as well as the ionic compositions of the internal and external solutions in which 
the electrodes are sitting. For this reason, the osmolarity gradient that is created as a 
result of the internal and external solutions being 285 mOsm and 298 mOsm, 
respectively, is a vital parameter that must be established to ensure the integrity of the 
experiment.  Therefore, we regularly monitored the osmolarities of our solutions using a 
vapor pressure osmometer (VAPRO® Vapor Pressure Osmometer, Model 5600). All of 
our solutions were filtered through 0.22 μm filters (Millipore GS Syringe Filter Unit, 
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mixed cellulose esters, 33 mm, ethylene oxide sterilized) to ensure purity. Our stock 
buffer solutions were kept at -40ºC and thawed just before using. 
Silver Wire Electrodes 
We chlorided our internal and external silver wire electrodes daily by first sanding 
them with emery cloth, and then soaking them in fresh Clorox Bleach for approximately 
15-20 minutes.  As the silver wires become chlorided, their color visibly changes from 
silver to black. During experimentation, as ions flow between the electrodes, one 
becomes darker black (more chlorided) while the other begins to turn white 
(dechlorided). After soaking in bleach, the electrodes were thoroughly rinsed in double-
distilled deionized water. This step is essential in preventing any excess ions from 
coming off into solution and interfering with the extremely sensitive, electrophysiological 
experiments. We found that we needed to rechloride our electrodes at least once a day, 
though on occasion, two or three times (if we noticed one of them beginning to turn 
white).
Cells
Erythrocytes were isolated from whole blood (drawn by and retrieved directly 
from the NIH Blood Bank).  At the NIH Blood Bank, samples were drawn from healthy 
Caucasian adults (18+ years) and kept at room temperature in a specified tube containing 
anticoagulant and ACD (Trisodium Citrate, Citric Acid, Dextrose). In our lab, the whole 
blood was centrifuged (700 RCF, 4º C, for 10 minutes). The serum and buffy coat were 
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aspirated from the top, replaced with PBS (free of Ca2+ and Mg2+) and centrifuged again.  
This was repeated three more times, for a total of five centrifugations.
To make the stable HA-expressing cell line, NIH3T3 cells from the American 
Tissue Culture Collection CRL-1658 were transfected with a linearized plasmid that 
encodes HA gene and Kan/Neo resistance gene. This plasmid was constructed from the 
phCMV1 vector (Genlantis, # P003100) after cloning of the hemagglutinin gene
[Influenza A virus (A/Japan/305/57(H2N2))] under the direction of a promoter, specially 
modified for high-level expression. Lipofectamine2000 (Invitrogen, # 11668) was used 
for cell transfection.  Forty eight hours after transfection, cells were trypsinized and 
subsequently re-plated in 96-well plates at a dilution of 1:500 and placed under Geneticin 
selection (Invitrogen, # 10131). The medium containing 500ug/ml of Geneticine was 
replaced every other day for the next 14 days.  At approximately two weeks, individual 
colonies were picked and extended for growth in 24-well plates. Cells were screened for 
HA expression. The density of HA-expressing fibroblasts used was approximately 5x106
cells per mL. 
Red blood cells and HA-expressing fibroblasts were bound together (though not 
yet fused) before being patched. The protocol for binding these cells is as follows: the 
clone 15 cell line was obtained using standard techniques for selecting stably transfected 
cells as described above. Clone 15 cells were then seeded in a 75 cm tissue-culture flask 
(5x105 cells/flask) and grown at 37ºC and 5% CO2 in DMEM-10% Calf  Bovine Serum,
supplemented with l-glutamine and primocin. 48 hours later, expressed HA0 (HA 
precursor) was cleaved to its fusion competent form: HA1-S – S-HA2. Clone 15 cells 
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were washed twice with PBS and lifted from the dish via trypsinization (TPCK-treated 
trypsin (10 μg/ml)) in the presence of exogenous bacterial-neuraminidase from 
Clostridium perfrigens (Sigma-Aldrich) (0.2 mg/ml) for five to eight minutes, at 37ºC. 
The reaction was terminated by washing cells in full DMEM containing 10% Calf Bovine 
Serum. The cells were subsequently washed twice with PBS. The cell suspension was 
mixed with the isolated red blood cells (~0.01%), as described above, and incubated on a 
rotator for 20 minutes at room temperature. The unbound red blood cells were removed 
as they were washed twice in PBS. The HA-expressing cells with bound erythrocytes 
(~1-3per cell) were detected by light microscopy and then suspended in standard seal 
solution before patching.  The density of HA-expressing fibroblast and red cell pairs was 
approximately 1x106 cells per mL of seal solution.  
Patchmaster and PatchControl Software
In order to acquire data throughout our experiments, a great deal of cross-talk and 
data processing exists between various hardware and software systems. Information that 
is detected by the recording electrodes must be amplified by several orders of magnitude 
before we are able to appreciate any electrical activity at the cellular level. Therefore, the 
electrical activity that gets detected by the Ag/AgCl2 electrodes at the recording chip is 
sent directly to a HEKA EPC 10 USB amplifier (HEKA Elektronik, Harvard Bioscience, 
Inc.). This amplifier has a built-in data acquisition system, allowing it to process and 
amplify the electrical signal it receives.  The amplifier then relays this information to the 
HEKA Patchmaster program – the computer software we use to record our data. 
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The first step in each experiment is to record the initial resistance across the NPC-
1 recording chip. 5 μL of standard internal buffer solution is added to the inner face of 
the chip. The chip is screwed onto the low-noise apparatus, and 5 μL of seal solution is 
added to the top of the chip.   As ions from these solutions pass through the aperture of 
the chip, the electrodes detect this activity and relay it to the amplifier. Simultaneously, 
we are able to observe a resistance reading of ~5 – 10 MOhm in the Patchmaster window.  
Once we see that the resistance across the chip falls within the designated range, 5 
μL of cell suspension (erythrocytes bound to HA-expressing fibroblasts) is added to the 
top of the chip. A suction unit (Nanion Technologies GmbH) facilitates the formation of 
a GOhm seal by applying negative pressure through the aperture from the inner face of 
the chip. This suction unit is controlled by a second software program – PatchControl 
(Nanion Technologies GmbH). In PatchControl, a pre-programmed parameter file is 
loaded which facilitates a step-by-step procedure towards creating a tight seal.  We use a 
“fragile” parameter file, which commands the suction unit to first apply a brief 20 mbar 
of positive pressure to the inner face of the recording chip just before cell suspension is 
added.  Upon addition of the cell suspension, it immediately switches to a -200 mbar of 
negative pressure, drawing a cell out of suspension and into the aperture.  This suction is 
turned off once a GOhm seal is detected. At this stage, the system is in the “cell-attached” 
configuration. In order to achieve whole cell configuration, a command voltage of -80
mV is applied, in addition to short pulses of -20 mbar suctions until the cell membrane 
(on the inner face of the chip) is ruptured.  
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Since our cell suspension consists of erythrocytes bound to HA-expressing 
fibroblasts, it is possible to initially patch either one of the two cell types.  In order to 
determine which cell we have patched, we use PatchMaster to obtain a capacitance 
measurement. If the resulting capacitance falls within 1-2 pF, we conclude that an 
erythrocyte has been patched.  If the capacitance is much larger (~40 pF), we assume that 
we are recording from an HA-expressing fibroblast. We also record the initial 
conductance from our patched cell. These initial measurements serve as baseline values 
for capacitance and conductance before fusion occurs.
Since we are interested in observing the real-time electrophysiological changes 
associated with the fusion event, we also obtain continuous conductance and capacitance 
readings throughout our entire experiment. As explained in the introduction, if voltage is 
constant, it is impossible to obtain a continuous recording of capacitance. The HEKA 
EPC 10 amplifier is a lockin amplifier, which allows us to apply a command voltage to 
our cell in the form of a sinewave (frequency of 1 KHz), and record the resulting 
capacitance of the membrane continuously over the course of the experiment. The 
holding potential of the cell is kept at -80 mV. We begin recording from our unfused cell 
pair, and then attempt to facilitate the fusion event mid-recording in an effort to observe 
even the first milliseconds of the fusion event.
To initiate the fusion event, we manually perfuse the cell suspension with our 
fusion buffer. 20 μL of low-pH buffer is gently added to one side of the chip with a 
pipette, whereas not to disturb or dislodge the patched seal from the aperture, while 20 
μL is removed from the opposite side. This is repeated approximately 4 more times to 
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ensure that all of the initial solution has been replaced with fusion buffer and therefore 
the pH of the external solution is adequately lowered to 4.9. We monitor the progression 
of our experiment in real-time on the PatchMaster oscilloscope throughout the entire 
experiment.
 
 
RESULTS
Our goals for this experiment were to measure fusion pore conductance at 
millisecond time resolution using both wild type and mutant engineered HA-expressing 
fibroblasts. Given the finite amount of time allotted to complete this project, we have not 
yet been able to generate data that would enable us to support or reject our hypotheses 
regarding the dynamic, initial opening of the fusion pore. Our ability to analyze the 
electrophysiological characteristics of the initial opening of the fusion pore is contingent 
upon observing the fusion event via an increase in membrane capacitance – a
phenomenon that has already been demonstrated in many labs (Fernandez et al., 1984; E
Neher & Marty, 1982; Manfred Lindau & Neher, 1988; Zimmerberg et al., 1987).
Unfortunately, we have not yet been in able to reproduce this phenomenon, which is 
necessary for subsequent analysis of fusion pore conductance. Furthermore, as we are 
still trying to optimize the experimental conditions that we hope will allow us to observe 
the fusion pore using wild type HA, we have not yet moved experimented with mutant 
HA. 
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Though we were not able to observe fusion between a patched cell (either 
erythrocyte or fibroblast) and its bound counterpart, we were in fact able to successfully 
record baseline data from various cells in suspension.  Our experimental approach was to 
first patch onto a cell – presumably one that is bound by the opposite cell type, as
determined under the microscope by verification of ~85% of fibroblasts bound by at least 
one erythrocyte – and obtain a baseline recording of capacitance prior to membrane 
fusion.  Upon fusion following the addition of low pH buffer, we would subsequently be 
able to observe the expected step-wise increase in membrane capacitance in real-time. 
While we were never able to observe this capacitance increase, we were able to obtain the 
initial baseline continuous capacitance recordings from cells in whole cell configuration, 
prior to the main fusion event (figure 5). The continuous recording (5A) is the first of 23 
sweeps recorded from this cell. As each sweep is 13 seconds, we record for 23 sweeps in 
order to obtain a continuous 299 second (~5 minute) recording.
A sine wave with a frequency of 1 kHz is applied over the course of the 
recording, enabling us to measure capacitance of the cell membrane continuously. It is 
important to note that the negative values associated with the capacitance measurements 
correspond to a phase shift between voltage and current across the capacitor (membrane). 
Therefore we look at its absolute value to determine what type of cell (erythrocyte or 
fibroblast) has been patched. When the patched cell was held at -80 mV, the resulting -
1.82 pF measurement lead us to believe that we had patched onto an erythrocyte, whose 
expected capacitance is 1-2 pF.  During the 3rd sweep (approximately 40 seconds after the 
start of the recording) the cell was manually perfused with low pH buffer to activate the 
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HA fusion peptide.  We were unable to observe any sign of the fusion event occurring, as 
the capacitance remained stable throughout the course of the experiment (5B).  
Figure 5: Continuous capacitance recordings from erythrocyte. A. A continuous 
capacitance recording of the first sweep (prior to adding low pH fusion buffer) upon 
achieving whole cell configuration in an erythrocyte. A lockin sine wave (1 kHz) was 
applied throughout. B. Continuous capacitance recording during the 23rd sweep (~5 
minutes after sweep 1). Low pH fusion buffer was added at the 3rd sweep (not pictured).
The fusion event was not observed, as capacitance has not increased from sweep 1 to 
sweep 23.  
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The baseline data we were able to collect was, in fact, promising in respect to 
both noise-level and time resolution. This suggests that should we observe the fusion 
event in future experiments, our low-noise apparatus and software would allow enable us 
to measure even the small, rapid changes in electrical activity across the membrane, 
characteristic of the initial fusion pore opening. The expected magnitude of capacitance 
Figure 6: Noise Level: Capacitance Measurement. A lockin capacitance measurement 
was obtained upon application of 1 kHz sine wave to erythrocyte in whole cell 
configuration. 10 data points were recorded at time intervals of approximately 170 ms 
apart. All 10 points are plotted on the same graph and have values -1.90 fF (Y-axis). A 
lack of detectable variation in the 0.01 pF range indicates that any noise in the system 
must be at least one order of magnitude lower. Therefore, we know that there is less than 
10 fF of noise.  
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increase is dependent on which cell type of the bound pair gets directly patched first. If 
we first patch an erythrocyte (1-2 pF capacitance), then we would expect to see a 
relatively large jump in capacitance as it fuses with a fibroblast whose expected 
membrane capacitance is ~40 pF.  However, if we first patch onto a fibroblast, then we 
would expect to see the opposite: a very small increase of 1-2 pF upon fusion. In order to 
observe this small change, the signal-to-noise ratio of our recordings must be optimal; 
otherwise the fusion event might be misinterpreted as noise, or missed all together. We 
were able to consistently record from cell membrane capacitance with less than 10 fF of 
noise.  
As can be seen in the graph in figure 6, capacitance measurements are recording 
from the same cell every ~170 ms for a total of 10 data points.  Each of the points is 
graphed at -1.90 pF.  What this tells us is that any variation capacitance measurements 
from this single cell must be smaller than 10 fF. In other words, this graph shows us that 
we can measure capacitance with less than 10 fF of noise. This suggests that in the event 
of patching onto a fibroblast first, we would be able to distinguish the 1-2 pF change in 
capacitance resulting from the fusion event from unwanted noise in the system. 
DISCUSSION
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 Given the fact that we were not in fact able to observe the fusion event via an 
increase in membrane capacitance, there are various aspects of our experiments which 
could be improved and applied to future experimentation. One of the main reasons that I 
believe we were not able to see fusion events between our red blood cells and HA-
expressing fibroblasts is that we did not have the ability to see exactly what we were 
patching onto.  In traditional patch clamping, the experimenter typically uses an inverted 
microscope (to maximize workspace, as opposed to an upright microscope,) to locate and 
patch onto a choice cell.  The Port-a-Patch apparatus does not come with microscope 
capabilities, as the entire procedure is automated and a microscope is not necessary for 
physically patching onto a cell.  However, this is problematic when trying to obtain 
whole cell recordings from a suspension of more than one cell type.  The suction that is 
applied to capture is cell is completely non-specific, as the first cell to get lodged into the 
aperture is the one that we were forced to obtain our recordings from. Since we were not 
able to look through a microscope, we relied on characteristic electrophysiological 
measurements to determine which type of cell we were recording from – erythrocyte or 
fibroblast. In other words, once whole cell configuration was achieved, we would to 
determine which of the two cell types we had patched based on the resulting capacitance 
measurement.  If the capacitance reading was ~1-2 pF, we assumed that we had patched 
onto a red blood cell; however, if it was ~40pF, we would assume that we were recording 
from an HA-expressing fibroblast. With a microscope, we would know exactly which cell 
type we were recording from, avoiding such assumptions altogether.  Furthermore, we 
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would have the ability to target a specific cell in suspension, to ensure that the cell being 
recorded from was, in fact, bound by the opposite cell type. 
Our failure to observe the fusion event could also be due to the inability of our 
low-pH fusion buffer to elicit a conformational change in HA, altogether. When we 
looked at our HA-expressing fibroblasts under the microscope, we found that 
approximately 85% of them were bound by at least one red cell. Therefore, it is unlikely 
(though not impossible) that our ability to record from an initial cell, but inability to see a 
fusion event, was due to the fact that we were continually patching onto unbound cells 
floating in suspension, to which adding the low pH buffer would have no effect.  Instead, 
perhaps the low pH buffer was failing to elicit the necessary conformational change in 
HA. 
As discussed, HA is entirely unable to initiate the fusion event if it is not activated 
through exposure to a low pH environment. The pH of our fusion buffer was monitored 
very closely to ensure that it accurately mimicked the pH of the late endosome (4.9). For 
this reason, it is more likely that our perfusion methods for buffer exchange, rather than 
the pH of the buffer itself, were inadequate for eliciting fusion.  As the cells – prior to 
fusion – are initially suspended in external seal solution with a pH of 7.4, the low pH 
fusion buffer must not be added to the chip in addition to – but rather in exchange for –
the initial seal solution (to ensure the true pH is 4.9, and not somewhere in between 7.4 
and 4.9). This can be achieved in two ways. One way is to use a perfusion system 
specifically designed for rapid change of solutions. 
 35 
The other option is to manually exchange the solutions with a pipette, by adding 
the low pH fusion buffer to one side of the chip, while removing seal solution from the 
opposite side.  This is completed a number of times until the old solutions has been 
sufficiently exchanged for the new. The Port-a-Patch does come with a perfusion system; 
however, it is not compatible with the low-noise apparatus that we use for our 
experiments.  For these reason, we had initially decided to manually perfuse the 
recording chip through buffer exchange using a pipette. We are currently setting up the 
perfusion system with the slightly higher noise Port-a-Patch apparatus to test the 
hypothesis that our inability to observe the fusion event is due to insufficient perfusion of 
the low pH buffer. 
While there is frustration in not being to complete an experiment as expected, or 
as quickly as anticipated, learning from our mistakes and improving our current methods 
are promising for future experimentation. For the reasons mentioned above, we are 
currently in the process of setting up a traditional electrophysiology rig in our lab, which 
will allow us to study the fusion pore through patch clamping under an inverted 
microscope.  Furthermore, we will be using a cell chamber that is compatible with a 
perfusion system (as opposed to manually perfusing our cell) to ensure optimal 
conditions for observing the low-pH induced fusion event. 
Since traditional and automated patch clamping both have their advantages and 
disadvantages, we believe that studying the fusion pore in parallel on two different rigs 
will enhance our chances of observation of the fusion event between erythrocytes and 
HA-expressing fibroblasts. If we are in fact able to observe this fusion event, our plans 
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for future experimentation include optimizing noise-level and time resolution for 
measuring fusion pore conductance during initial pore opening. From there, we would 
hope to include the fibroblast expressing mutant HA in our experiments, to compare the 
structure-function relationships of the mutant and wild type HA. Though we were not 
able to observe the fusion event for this project, we do believe that future 
experimentation using fusion pore conductance to investigate the effects of HA’s 
structure on infection by influenza virus are both promising and necessary. 
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